Table 1 Clinicopathologic characteristics of studied patient and expression of SOX9 in NSCLC
| Â | No. (%) |
|---|---|
Gender | Â |
Male | 103(72.5) |
Female | 39(27.5) |
Age (years) | Â |
≤ 65 | 89(62.7) |
>65 | 53(37.3) |
Pathology | Â |
Squamous cell carcinoma | 47(33.1) |
Adenocarcinoma | 68(47.9) |
Adenosquamous carcinoma | 27(19.0) |
NSCLC histology (AJCC grade) | Â |
I | 32(22.5) |
II | 25(17.6) |
III | 58(40.8) |
IV | 27(19.0) |
Survival (n = 89) | Â |
Alive | 33(37.1) |
Dead | 56(62.9) |
Survial time of low expression | Â |
   Mean 31.70 |  |
   Median 28.50 |  |
Survival time of high expression | Â |
   Mean 24.84 |  |
   Median 24.00 |  |
Expression of SOX9 | Â |
Negative | 7(4.9) |
Positive | 135(95.1) |
Low expression | 68(47.9) |
High expression | 74(52.1) |